BioSpace News Archive

Three prominent clinical research experts from CBH Health and Research Centers of America, both CenExel Clinical Research Centers of Excellence, will report perspectives and insights on clinical trial impacts from COVID-

Purolite Corporation is expanding its manufacturing capabilities to address and fulfill the increasing global demand for its pharmaceutical and life science products.

Ellodi Pharmaceuticals, a gastroenterology-focused specialty pharmaceutical company, today announced an oral presentation by Professor Evan Dellon M.D., M.P.H, at the American College of Gastroenterology (ACG) 2020 Annual Scientific Meeting and Postgraduate Course, highlighting the results of APT-1011 (fluticasone propionate oral disintegrating tablet) in

POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today announced that members of the Poxel management and scientific team will participate at several upcoming scientific and investor conferences. B. Riley Liver Disease Therapeutics Day Date: October

QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today announced it would hold a conference call on Wednesday, October 28, after releasing full results for the third quarter and first nine months of 2020 on Tuesday, October 27. The call is scheduled for 14:00 Frankfurt time / 13:00 London time / 9:00 New York time. It will be hosted by Thierry Bernard, Chief Executive Officer, and Roland Sackers, Ch

Unprecedented clinical study results presented at Infectious Diseases Society of America (IDSA) Annual Conference, IDWeek 2020

Two Japanese institutions, a Korean biotechnology start-up, and a Canadian biotech company have entered into a research collaboration to identify biomarkers unique to lung cancer cells suitable for targeted therapeutics.

With ‘s advanced IOL technology, the need for glasses after cataract surgery has become a thing of the past.

Los Angeles- and Raleigh-based Gemelli Biotech announced the launch of a novel breath test called trio-smart™ that provides a more complete fermented gas profile of a patient’s microbiome by measuring levels of hydrogen, methane, and hydrogen sulfide after the consumption of a sugar substance (lactulose or glucose)

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle, and Chief Scientific Officer, Dr. Kenneth Cundy, will participate on the panel titled “Direct Antivirals and Other Agents Against SARS-CoV2 Virus” at the ROTH Capital COVID-19 Therapeutic